172
Views
5
CrossRef citations to date
0
Altmetric
Articles

3D-QSAR analysis of a series of S-DABO derivatives as anti-HIV agents by CoMFA and CoMSIA

, , &
Pages 999-1014 | Received 13 Jun 2016, Accepted 04 Sep 2016, Published online: 26 Sep 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yanjun Zhang, Lu Chen, Zhonghua Wang, Yiren Zhu, Huifang Jiang, Jie Xu & Fei Xiong. (2023) Design of novel DABO derivatives as HIV-1 RT inhibitors using molecular docking, molecular dynamics simulations and ADMET properties. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-18.
Read now

Articles from other publishers (4)

Aizhen Zhou, Li Wang, Jie Zou, Shuwei Ma, Yahong Zhou, Juan Wang, Na Li & Bin Cheng. (2023) Exploring the Potential of Vortioxetine Derivatives as Inhibitors of SARS‐CoV‐2 Main Protease: A Computational Study. ChemistrySelect 8:41.
Crossref
Yanni Lai, Yiwen Yan, Shanghui Liao, Yun Li, Yi Ye, Ni Liu, Fang Zhao & Peiping Xu. (2020) 3D-quantitative structure–activity relationship and antiviral effects of curcumin derivatives as potent inhibitors of influenza H1N1 neuraminidase. Archives of Pharmacal Research 43:5, pages 489-502.
Crossref
Bikash Kumar Sarkar, Ananda Sarkar & Atish Dipankar Jana. (2020) Non-Nucleoside HIV-1 Reverse Transcriptase Inhibition Activity of a Series of Dihydroalkoxybenzyloxopyrimidine (DABO) Derivatives: CoMFA, CoMSIA and Docking Studies. Asian Journal of Organic & Medicinal Chemistry 5:3, pages 265-272.
Crossref
V. Ravichandran, K. Rohini, R. Harish, S. Parasuraman & K. Sureshkumar. (2019) Insights into the key structural features of triazolothienopyrimidines as anti-HIV agents using QSAR, molecular docking, and pharmacophore modeling. Structural Chemistry 30:4, pages 1471-1484.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.